Cellectar Biosciences (CLRB) Reports Q2 Loss of $0.30/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/5/2026
Go back to Cellectar Biosciences (CLRB) Reports Q2 Loss of $0.30/Share
August 12, 2015 4:30 PM EDT
MADISON, Wis., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), today announces financial results for the second quarter of 2015.
During the second quarter of 2015, the company reported a net loss for of $2.3 million or ($0.30) per share versus a net loss of $2.1 million or ($0.73) per share for the comparable period in 2014. Research and development expenses for the quarter ended June 30, 2015 were $1.4 million, similar to the second quarter from the year prior.
Cellectar's general and administrative expenses for second quarter 2015 totaled $0.8 million, reflecting a $0.1 million decrease from the comparable prior year period.
... More
August 12, 2015 4:30 PM EDT
MADISON, Wis., Aug. 12, 2015 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), today announces financial results for the second quarter of 2015.
During the second quarter of 2015, the company reported a net loss for of $2.3 million or ($0.30) per share versus a net loss of $2.1 million or ($0.73) per share for the comparable period in 2014. Research and development expenses for the quarter ended June 30, 2015 were $1.4 million, similar to the second quarter from the year prior.
Cellectar's general and administrative expenses for second quarter 2015 totaled $0.8 million, reflecting a $0.1 million decrease from the comparable prior year period.
... More
